Ligand ID: RKE Drugbank ID: DB01221(Ketamine) Indication:Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior other general anesthetic agents and as a supplement of low potency agents.[L1336, FDA label] |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2ajf | SPIKE PROTEIN (SARSr-CoV) | 4 / 8 | ASP F 392ASP F 393VAL F 337PHE F 483 | 1.05A | 18.67 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2dd8 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP S 392ASP S 393VAL S 337PHE S 483 | 1.06A | 19.94 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | ASP A 64ASP A 64VAL A 78LEU A 93 | 1.01A | 17.35 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2ghw | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP C 392ASP C 393VAL C 337PHE C 483 | 1.25A | 19.94 | CL C 20 ( 4.9A)NoneNoneNone | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 8 | ASP B 300VAL B 236PHE B 221LEU B 227 | 1.23A | 22.38 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 8 | ASP C 300VAL C 236PHE C 221LEU C 227 | 1.24A | 22.38 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3bgf | SPIKE PROTEIN S1 (SARSr-CoV) | 4 / 8 | ASP A 392ASP A 393VAL A 337PHE A 483 | 1.18A | 20.07 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3d0g | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP F 392ASP F 393VAL F 337PHE F 483 | 1.18A | 18.99 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3d0h | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP F 392ASP F 393VAL F 337PHE F 483 | 1.23A | 18.99 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3d0i | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP E 392ASP E 393VAL E 337PHE E 483 | 1.24A | 19.30 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3i6k | BETA-2-MICROGLOBULIN (Homosapiens) | 4 / 8 | ASP B 34VAL B 82PHE B 30LEU B 64 | 1.39A | 16.88 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3sci | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP F 392ASP F 393VAL F 337PHE F 483 | 1.20A | 21.45 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3scj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP E 392ASP E 393VAL E 337PHE E 483 | 1.21A | 18.67 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3sck | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP E 392ASP E 393VAL E 337PHE E 483 | 1.17A | 18.99 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 3scl | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP F 392ASP F 393VAL F 337PHE F 483 | 1.32A | 18.67 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 4 / 8 | ASP A 302VAL A 268LEU A 284LYS A 291 | 1.34A | 19.73 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 8 | ASP B 376VAL B 369PHE B 379LEU B 503 | 1.26A | 13.53 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | TYR B 494ASP B 392ASP B 393PHE B 483 | 1.25A | 14.04 | TYR B 494 ( 1.3A)ASP B 392 ( 0.5A)ASP B 393 ( 0.5A)PHE B 483 ( 1.3A) | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ASP B 392ASP B 393VAL B 337PHE B 483 | 1.14A | 14.04 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 8 | ASP A 392ASP A 393VAL A 337PHE A 483 | 1.17A | 14.02 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6m1d | ACE2 (Homosapiens) | 4 / 8 | TYR B 649ASP B 713PHE D 715LEU D 642 | 1.17A | 16.81 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6nus | NSP12 (SARSr-CoV) | 4 / 8 | TYR A 175ASP A 164PHE A 134LEU A 142 | 1.31A | 15.03 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6vw1 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ASP E 405ASP E 406VAL E 350PHE E 497 | 1.25A | 19.17 | None | ||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | TYR L 186ASP L 122VAL L 133PHE L 209 | 1.72A | 20.00 | None | ||
![]() | 4F8H_E_RKEE401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | VAL L 64LYS B 0TYR L 42ASP H 107 | 1.76A | NoneMLI B 303 (-4.6A)NoneNone | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.75A | None | |||
![]() | 4F8H_C_RKEC401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 42ASP H 107VAL L 64LYS B 0 | 1.78A | NoneNoneNoneMLI B 303 (-4.6A) | |||
![]() | 4F8H_D_RKED401_1 (PROTON-GATED IONCHANNEL) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.79A | None | |||
![]() | 4F8H_C_RKEC401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 42ASP B 107VAL C 64LYS H 0 | 1.76A | NoneNoneNoneMLI B 303 (-4.3A) | |||
![]() | 4F8H_D_RKED401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 42ASP B 107VAL C 64LYS H 0 | 1.75A | NoneNoneNoneMLI B 303 (-4.3A) | |||
![]() | 4F8H_C_RKEC401_1 (PROTON-GATED IONCHANNEL) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.79A | None | |||
![]() | 4F8H_D_RKED401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 42ASP H 107VAL L 64LYS B 0 | 1.76A | NoneNoneNoneMLI B 303 (-4.6A) | |||
![]() | 4F8H_B_RKEB401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 42ASP H 107VAL L 64LYS B 0 | 1.74A | NoneNoneNoneMLI B 303 (-4.6A) | |||
![]() | 4F8H_B_RKEB401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 42ASP B 107VAL C 64LYS H 0 | 1.73A | NoneNoneNoneMLI B 303 (-4.3A) | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 42ASP B 107VAL C 64LYS H 0 | 1.77A | NoneNoneNoneMLI B 303 (-4.3A) | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR C 192ASP C 128VAL C 139PHE C 215 | 1.71A | None | |||
![]() | 4F8H_E_RKEE401_1 (PROTON-GATED IONCHANNEL) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 8 | VAL C 64LYS H 0TYR C 42ASP B 107 | 1.74A | NoneMLI B 303 (-4.3A)NoneNone | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6ym0 | LIGHT CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.72A | None | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR C 192ASP C 128VAL C 139PHE C 215 | 1.75A | None | |||
![]() | 4F8H_C_RKEC401_1 (PROTON-GATED IONCHANNEL) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.79A | None | |||
![]() | 4F8H_D_RKED401_1 (PROTON-GATED IONCHANNEL) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR C 192ASP C 128VAL C 139PHE C 215 | 1.79A | None | |||
![]() | 4F8H_A_RKEA401_1 (PROTON-GATED IONCHANNEL) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.75A | None | |||
![]() | 4F8H_D_RKED401_1 (PROTON-GATED IONCHANNEL) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 8 | TYR L 192ASP L 128VAL L 139PHE L 215 | 1.79A | None |